Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  284.02
+12.44 (4.58%)
AAPL  303.42
-5.49 (-1.78%)
AMD  484.64
+8.49 (1.78%)
BAC  62.48
+0.53 (0.86%)
GOOG  372.47
+15.82 (4.44%)
META  590.24
+33.53 (6.02%)
MSFT  487.65
+22.93 (4.93%)
NVDA  206.64
+5.89 (2.93%)
ORCL  141.85
+11.98 (9.22%)
TSLA  322.08
+10.87 (3.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.